- Patent Title: Selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
-
Application No.: US15745754Application Date: 2016-07-07
-
Publication No.: US10550097B2Publication Date: 2020-02-04
- Inventor: Stéphanie Boudon , Piero Geotti-Bianchini , Marc Heidl , Eileen Jackson , Alexander Schlifke-Poschalko
- Applicant: DSM IP ASSETS B.V.
- Applicant Address: NL Heerlen
- Assignee: DSM IP ASSETS B.V.
- Current Assignee: DSM IP ASSETS B.V.
- Current Assignee Address: NL Heerlen
- Agency: Nixon & Vanderhye P.C.
- Priority: EP15178034 20150723
- International Application: PCT/EP2016/066182 WO 20160707
- International Announcement: WO2017/012890 WO 20170126
- Main IPC: C07D401/10
- IPC: C07D401/10 ; A61K8/49 ; A61Q19/08 ; C07D223/04 ; C07D265/30 ; C07D211/16
Abstract:
The present invention relates to novel selective 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors and the use thereof to prevent age-induced skin structure and function defects.
Public/Granted literature
- US20180208576A1 NOVEL SELECTIVE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 Public/Granted day:2018-07-26
Information query
